Investigation Overview
March 10, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Peregrine Pharmaceuticals (NASDAQ:PPHM) shares over potential securities laws violations by Peregrine Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers...
You must register (for free) or login to view the entire investigation.